Sector Chart Burning Rock Biotech Limited

Stocks

BNR

US12233L2060

Healthcare Facilities & Services

Delayed Nasdaq 18:35:10 29/09/2026 BST			5-day change	1st Jan Change
18.82 ^USD	+6.75%		+14.41%	-6.60%

09-10	Burning Rock Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2026	CI
07-20	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Medical & Diagnostic Laboratories

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
BURNING ROCK BIOTECH LIMITED	186M	-	-	-	-	-
NATERA, INC.	59.35B					-
LABCORP HOLDINGS INC.	25.11B
SONIC HEALTHCARE LIMITED	6.59B
RADNET, INC.	5.65B			-	-
DR. LAL PATHLABS LIMITED	3.38B